Forsberg, Matthew H, Das, Amritava, Saha, Krishanu, and Capitini, Christian M. The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL. Retrieved from https://par.nsf.gov/biblio/10208792. Therapeutics and Clinical Risk Management Volume 14. Web. doi:10.2147/TCRM.S146309.

Forsberg, Matthew H, Das, Amritava, Saha, Krishanu, & Capitini, Christian M. The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL. Therapeutics and Clinical Risk Management, Volume 14 (). Retrieved from https://par.nsf.gov/biblio/10208792. https://doi.org/10.2147/TCRM.S146309

Forsberg, Matthew H, Das, Amritava, Saha, Krishanu, and Capitini, Christian M. "The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL". Therapeutics and Clinical Risk Management Volume 14 (). Country unknown/Code not available. https://doi.org/10.2147/TCRM.S146309. https://par.nsf.gov/biblio/10208792.

@article{osti_10208792,
place = {Country unknown/Code not available}, title = {The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL}, url = {https://par.nsf.gov/biblio/10208792}, DOI = {10.2147/TCRM.S146309}, abstractNote = {}, journal = {Therapeutics and Clinical Risk Management}, volume = {Volume 14}, author = {Forsberg, Matthew H and Das, Amritava and Saha, Krishanu and Capitini, Christian M}, editor = {null} }